TGF-ß signalopathies as a paradigm for translational medicine.

Cannaerts, Elyssa; van de Beek, Gerarda; Verstraeten, Aline; Van Laer, Lut; Loeys, Bart

Cannaerts, Elyssa; van de Beek, Gerarda; Verstraeten, Aline; Van Laer, Lut; Loeys, Bart.

Affiliation

Cannaerts E; Center of Medical Genetics, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium. Electronic address: bart.loeys@uantwerpen.be.
van de Beek G; Center of Medical Genetics, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.
Verstraeten A; Center of Medical Genetics, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.
Van Laer L; Center of Medical Genetics, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.
Loeys B; Center of Medical Genetics, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium; Department of Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.

Eur J Med Genet ; 58(12): 695-703, 2015 Dec.

Article de En | MEDLINE | ID: mdl-26598797

Sujet(s)
Mots clés

Angiotensin receptor blocker; Beta blocker; Loeys-Dietz syndrome; Marfan syndrome; Shprintzen-Goldberg syndrome; Transforming growth factor beta

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Transduction du signal / Facteur de croissance transformant bêta / Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Animals / Humans Langue: En Journal: Eur J Med Genet Sujet du journal: GENETICA MEDICA Année: 2015 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google